Pour quels vaccins RFK mettra-t-il fin aux recommandations ?
$1,399,277 Vol.
Dec 31, 2025
Polio
$22,600 Vol.
Non
COVID-19
$602,048 Vol.
Non
VPH
$316,492 Vol.
Non
Grippe
$28,349 Vol.
Non
Hépatite B
$166,216 Vol.
Non
Rougeole, Oreillons et Rubéole
$263,573 Vol.
Non
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Créé le : Feb 21, 2025, 7:10 PM ET
Volume
$1,399,277Date de fin
Dec 31, 2025Créé le
Feb 21, 2025, 7:10 PM ETResolver
0x6A9D22261...Résultat proposé: Non
Aucune contestation
Résultat final: Non
Pour quels vaccins RFK mettra-t-il fin aux recommandations ?
$1,399,277 Vol.
Polio
$22,600 Vol.
Non
COVID-19
$602,048 Vol.
Non
VPH
$316,492 Vol.
Non
Grippe
$28,349 Vol.
Non
Hépatite B
$166,216 Vol.
Non
Rougeole, Oreillons et Rubéole
$263,573 Vol.
Non
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Frequently Asked Questions
"Pour quels vaccins RFK mettra-t-il fin aux recommandations ?" is a prediction market on Polymarket with 6 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "Polio" at 0%, followed by "COVID-19" at 0%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 0¢ implies that the market collectively assigns a 0% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.
As of today, "Pour quels vaccins RFK mettra-t-il fin aux recommandations ?" has generated $1.4 million in total trading volume since the market launched on Feb 22, 2025. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.
To trade on "Pour quels vaccins RFK mettra-t-il fin aux recommandations ?," browse the 6 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.
This is a wide-open market. The current leader for "Pour quels vaccins RFK mettra-t-il fin aux recommandations ?" is "Polio" at just 0%, with "COVID-19" close behind at 0%. With no outcome commanding a strong majority, traders see this as highly uncertain, which can present unique trading opportunities. These odds update in real-time, so bookmark this page to watch how the probabilities evolve.
The resolution rules for "Pour quels vaccins RFK mettra-t-il fin aux recommandations ?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.

Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Frequently Asked Questions